Key statistics
As of last trade Karyopharm Therapeutics Inc (25K:BRN) traded at 0.645, 0.00% below its 52-week high of 0.645, set on Sep 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.644 |
---|---|
High | 0.645 |
Low | 0.644 |
Bid | 0.627 |
Offer | 0.634 |
Previous close | 0.645 |
Average volume | -- |
---|---|
Shares outstanding | 125.31m |
Free float | 117.75m |
P/E (TTM) | -- |
Market cap | 112.51m USD |
EPS (TTM) | -0.7906 USD |
Data delayed at least 15 minutes, as of Sep 13 2024.
More ▼
Press releases
- Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
- Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
- Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024
- Karyopharm to Participate at Upcoming Investor Conferences
More ▼